Stratifying risk outcomes among adult COVID-19 inpatients with high flow oxygen: The R4 score.

ABSTRACT:

Background

High flow oxygen therapy (HFO) is a widely used intervention for pulmonary complications. Amid the coronavirus infectious disease 2019 (COVID-19) pandemic, HFO became a popular alternative to conventional oxygen supplementation therapies. Risk stratification tools have been repurposed -and new ones developed- to estimate outcome risks among COVID-19 patients. This study aims to provide a simple risk stratification system to predict invasive mechanical ventilation (IMV) or death among COVID-19 inpatients on HFO.

Methods

Among 529 adult inpatients with COVID-19 pneumonia, we selected unadjusted clinical risk factors for developing the composite endpoint of IMV or death. The risk for the primary outcome by each category was estimated using a Cox proportional hazards

SUBMITTER: Aguirre-Garcia GM 

PROVIDER: S-EPMC8506226 | biostudies-literature | 2023 May-Jun

REPOSITORIES: biostudies-literature